April 12th 2025
Scott A. Soefje, PharmD, MBA, BCOP, explained how the expanding use of the FDA’s 505(b)(2) drug approval pathway is creating operational and reimbursement challenges for oncology infusion centers.
9 in 10 Americans Support Federal Intervention in Drug Prices in Response to COVID-19 Pandemic
June 19th 2020According to a new study by West Health and Gallup, 88% of US adults support the federal government directly negotiating the price of a COVID-19 treatment with a drug manufacturer upon its availability due to concerns regarding raised drug prices.
Survey Shows Time-to-Fill Delays of Up to 10 Days for Specialty Prescriptions
May 14th 2020Survey finds that nearly two-thirds of specialty pharmacists spend more than 15 minutes on the phone to fill 1 prescription, whereas 79% of specialty pharmacists seek additional information from clinicians at least 3 times in an average day.